|
|
| | Hexanamide, 5-methyl-3-[[(2S)-3-methyl-1-oxo-2-[[[4-[(1E)-2-phenylethenyl]phenyl]sulfonyl]amino]butyl]amino]-2-oxo-, (3S)- Basic information |
| | Hexanamide, 5-methyl-3-[[(2S)-3-methyl-1-oxo-2-[[[4-[(1E)-2-phenylethenyl]phenyl]sulfonyl]amino]butyl]amino]-2-oxo-, (3S)- Chemical Properties |
| density | 1.218±0.06 g/cm3(Predicted) | | pka | 9.15±0.50(Predicted) |
| | Hexanamide, 5-methyl-3-[[(2S)-3-methyl-1-oxo-2-[[[4-[(1E)-2-phenylethenyl]phenyl]sulfonyl]amino]butyl]amino]-2-oxo-, (3S)- Usage And Synthesis |
| Uses | Calpain Inhibitor-2 (compound 5) is a peptide inhibitor of μ-calpain (Ki=9 nM). Calpain Inhibitor-2 exhibits antiproliferative activity against melanoma cell lines (A-375 and B-16F1) and PC-3 prostate cancer cells in vitro[1]. | | References | [1] Donkor IO,et al. Synthesis and antiproliferative activity of sulfonamide-based peptidomimetic calpain inhibitors. Bioorg Med Chem. 2020 May 1;28(9):115433. DOI:10.1016/j.bmc.2020.115433 |
| | Hexanamide, 5-methyl-3-[[(2S)-3-methyl-1-oxo-2-[[[4-[(1E)-2-phenylethenyl]phenyl]sulfonyl]amino]butyl]amino]-2-oxo-, (3S)- Preparation Products And Raw materials |
|